Page last updated: 2024-11-07

dextroamphetamine and Long QT Syndrome

dextroamphetamine has been researched along with Long QT Syndrome in 1 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schrantee, A1
Václavů, L1
Reneman, L1
Verberne, HJ1
Booij, J1
Tan, HL1

Other Studies

1 other study available for dextroamphetamine and Long QT Syndrome

ArticleYear
QT prolongation by dexamphetamine: Does experience matter?
    Journal of cardiovascular electrophysiology, 2017, Volume: 28, Issue:8

    Topics: Central Nervous System Stimulants; Dextroamphetamine; Electrocardiography; Female; Humans; Long QT S

2017